Laboratory Tests for Diagnosis and Management of PCOS
The essential laboratory tests for diagnosing and managing Polycystic Ovary Syndrome (PCOS) include total testosterone, free testosterone calculation, TSH, prolactin, 17-hydroxyprogesterone, fasting glucose/insulin ratio, and a 2-hour 75g oral glucose tolerance test with lipid profile. 1
Diagnostic Laboratory Tests
Hormonal Assessment for PCOS Diagnosis
- Total testosterone (TT): Should be measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for superior specificity (92%) with sensitivity of 74% and specificity of 86% 1
- Free testosterone (FT): Should be calculated rather than directly measured (sensitivity 89%, specificity 83%) 1
- Free Androgen Index (FAI): Sensitivity 78%, specificity 85% 1
- Androstenedione (A4): Sensitivity 75%, specificity 71% 1
- Dehydroepiandrosterone sulfate (DHEAS): Sensitivity 75%, specificity 67% 1
Tests to Exclude Other Causes of Hyperandrogenism
- Thyroid-stimulating hormone (TSH) to rule out thyroid dysfunction 1
- Prolactin levels to exclude hyperprolactinemia 1
- 17-hydroxyprogesterone to rule out congenital adrenal hyperplasia 1
- Overnight dexamethasone suppression test or 24-hour urinary free cortisol test to exclude Cushing's syndrome 1
Metabolic Evaluation
Insulin Resistance and Glucose Metabolism
- Fasting glucose/insulin ratio: A ratio >4 suggests normal insulin sensitivity; lower values indicate insulin resistance 1
- 2-hour 75g oral glucose tolerance test: Particularly important for women with BMI >25 kg/m² or other risk factors for glucose intolerance 1
Lipid Profile
- Complete fasting lipid profile: Total cholesterol, LDL, HDL, and triglycerides 1
Imaging Evaluation
- Transvaginal ultrasound: Should be performed between days 3-9 of the menstrual cycle 1
Clinical Pearls and Pitfalls
Common Diagnostic Pitfalls
- Misdiagnosing functional hypothalamic amenorrhea with polycystic ovarian morphology (FHA-PCOM) as PCOS phenotype D is a common error 1
- Relying solely on laboratory tests without considering clinical criteria: Remember that PCOS diagnosis requires at least two of three criteria (chronic anovulation, hyperandrogenism, polycystic ovaries) 1
- Using inappropriate testosterone assays: Immunoassays may lack specificity; LC-MS/MS is preferred 1
Important Considerations
- Laboratory evaluation should be interpreted in the context of clinical presentation, including menstrual irregularities, signs of hyperandrogenism, and ultrasound findings 1, 2
- The LH/FSH ratio may be elevated (>2:1 in 55% of patients, >3:1 in 26.2% of patients), but this is not included in the diagnostic criteria 3
- Regular metabolic screening is crucial due to the high risk of metabolic syndrome and type 2 diabetes in PCOS patients 1
Follow-up Laboratory Monitoring
- Annual metabolic screening: Fasting glucose, oral glucose tolerance test, and lipid profile 1
- Hormone levels: May be monitored to assess treatment response, particularly when using anti-androgen therapies 1
- Endometrial thickness: Should be monitored in patients with oligomenorrhea or amenorrhea 1
By following this comprehensive laboratory approach, clinicians can accurately diagnose PCOS, exclude other causes of hyperandrogenism, and monitor for metabolic complications that frequently accompany this syndrome.